Investors
Axela is a research and diagnostic tools company distinguished by: a proprietary technology, a distinctive business model and a seasoned management team that has successfully commercialized many Life Science tools & diagnostic products in the past. The underlying dot® technology of the company’s first-generation dotLab® System protein assay platform is uniquely positioned to provide researchers with research tools to generate tomorrow’s diagnostic opportunities.
The company has a number of ongoing collaborations which have generated data in the areas of cardiology, oncology, infectious disease and vaccine immune response that have the potential to address large, underserved diagnostic markets. The company is currently participating in two sponsor-funded clinical trials.
For Investor inquiries, please contact:
Axela Inc.
50 Ronson Drive
Suite 105
Toronto, ON M9W 1B3
Canada
Phone: 416-798-1625
Toll Free: 866-723-3363
Fax: 416-798-8635
No email inquiries, please.